Entero Therapeutics Inc. (ENTO)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.56
-0.01 (-2.61%)
At close: Jan 15, 2025, 11:46 AM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Cash & Equivalents | 3.71M | 1.36M | 8.25M | 6.06M | 175.80 | 1.11M | 573.47K | 1.77M | 581.67 | 94.84 | 48.23 |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 56.85 | 125.07 | n/a |
Long-Term Investments | 21.52K | 21.51K | n/a | n/a | n/a | n/a | 1.07M | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 11.25K | 39.66K | 44.01K | 27.92K | 41.05 | 2.54M | 30.92K | 3.63M | 25.64 | 20.31 | 17.35 |
Receivables | n/a | 93.01K | n/a | 551.49K | 2.64M | 3.17M | 1.10M | 961.04K | 1.07M | 428.75K | n/a |
Inventory | n/a | 1.95M | n/a | 1.25M | -2.64M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.24M | 1.96M | 1.18M | 1.26M | 595.19K | 512.98K | 274.96K | 229.41K | 353.98K | 14.80K | 884.93 |
Total Current Assets | 4.96M | 3.41M | 9.42M | 7.87M | 3.41K | 4.80M | 1.95M | 2.96M | 2.07K | 663.45 | 933.16 |
Property-Plant & Equipment | 210.00K | 303.10K | 409.31K | 92.57K | 159.78 | 128.85K | 133.99K | 151.62K | 176.32 | 211.72 | 43.39 |
Goodwill & Intangibles | 1.68M | 1.68M | 1.91M | 4.93M | 5.29K | 2.50K | 3.36K | 3.60K | 4.42K | 5.68K | n/a |
Total Long-Term Assets | 1.93M | 2.03M | 2.37M | 5.05M | 5.49K | 2.67M | 4.60M | 3.79M | 4.62K | 5.91K | 60.74 |
Total Assets | 6.88M | 5.44M | 11.79M | 12.92M | 8.90K | 7.47M | 6.55M | 6.75M | 6.69K | 6.58K | 993.90 |
Account Payables | 554.28K | 720.04K | 2.71M | 1.56M | 2.22M | 2.20M | 1.57M | 1.07M | 409.41K | 825.57K | 522.39 |
Deferred Revenue | n/a | 1.08M | 8.86M | 13.36M | n/a | 1.00 | n/a | -1.07K | n/a | 0.00 | n/a |
Short-Term Debt | 679.89K | 669.64K | 719.23K | 609.82K | 1.60M | 255.03K | 416.55K | 155.19K | 6.58M | 7.18K | n/a |
Other Current Liabilities | 1.90M | 1.09M | 8.87M | 13.38M | 464.17K | 538.29K | 489.38K | 1.11M | 1.83M | 553.00K | 214.06 |
Total Current Liabilities | 3.13M | 2.48M | 12.30M | 15.55M | 4.29K | 3.00M | 2.48M | 2.34M | 8.82K | 2.43K | 736.45 |
Long-Term Debt | 146.95K | 214.06K | 311.14K | 19.12K | n/a | n/a | n/a | n/a | n/a | n/a | 202.86 |
Other Long-Term Liabilities | n/a | n/a | 7.00M | n/a | n/a | n/a | 1.34M | 1.20M | 1.50M | 1.50M | -0.00 |
Total Long-Term Liabilities | 146.95K | 214.06K | 7.31M | 19.12K | n/a | n/a | 1.34M | 1.20M | n/a | n/a | 202.86 |
Total Liabilities | 3.28M | 2.70M | 19.61M | 15.56M | 4.29K | 3.00M | 3.82M | 3.54M | 8.82K | 2.43K | 939.30 |
Total Debt | 826.84K | 883.71K | 1.03M | 628.95K | 1.52K | 255.03K | 416.55K | 155.19K | 6.58K | 1.05K | 202.86 |
Common Stock | 156.00 | 5.00 | 7.00 | 312.00 | 2.68 | 1.77K | 1.21K | 963.00 | 0.43 | 0.36 | n/a |
Retained Earnings | -184.33M | -168.53M | -153.90M | -95.37M | -62.69K | -47.52M | -33.98M | -22.89M | -8.30K | -2.37K | -1.01K |
Comprehensive Income | 0.00 | n/a | -1.22M | -1.11M | -1.27M | -1.15M | -955.72K | -1.46M | -1.35K | -749.44 | 1.36 |
Shareholders Equity | 3.60M | 2.74M | -7.82M | -2.64M | 4.62K | 4.47M | 2.73M | 3.21M | -3.63K | 2.64K | 54.60 |
Total Investments | 21.52K | 21.51K | n/a | n/a | n/a | n/a | 1.07M | n/a | 56.85 | 125.07 | n/a |